Leadership changes, October 2026
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes
1,035
Appointments
576
Departures
68
Browse by role
October 2026
Get new CFO appointments the day the filing lands.
Filters
1,035 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | TEG OVERSEAS, INC. | Victor Balan | Director, President, Secretary, Treasurer and Chief Executive OfficerCEO | Departed | Jun 5, 2026 | SEC 8-K |
| Oct 14, 2026 | TEG OVERSEAS, INC. | Marcelo Ramon Alarcon Martinez | DirectorDirector | Departed | Jun 5, 2026 | SEC 8-K |
| Oct 14, 2026 | TEG OVERSEAS, INC. | Anna Toczko | DirectorDirector | Departed | Jun 5, 2026 | SEC 8-K |
| Oct 14, 2026 | TEG OVERSEAS, INC. | Elmurod Sopiev | Chief Executive OfficerCEO | Appointed | Jun 5, 2026 | SEC 8-K |
| Oct 14, 2026 | TEG OVERSEAS, INC. | Temur Zokirov | Chairman of the Board, Chief Financial Officer and SecretaryCFO | Appointed | Jun 5, 2026 | SEC 8-K |
| Oct 14, 2026 | TEG OVERSEAS, INC. | Bahtiyor Kadirov | DirectorDirector | Appointed | Jun 5, 2026 | SEC 8-K |
| Oct 14, 2026 | TEG OVERSEAS, INC. | Elina Davidyan | DirectorDirector | Appointed | Jun 5, 2026 | SEC 8-K |
| Oct 14, 2026 | Verastem, Inc. | Daniel W. Paterson | President and Chief Executive OfficerCEO | Departed | Jan 1, 2027 | SEC 8-K |
| Oct 14, 2026 | Verastem, Inc. | Michael Bailey | President and Chief Executive OfficerCEO | Appointed | Jan 1, 2027 | SEC 8-K |
| Oct 14, 2026 | XTI Aerospace, Inc. | Allan Evans | Class I directorClass I director | Appointed | Oct 14, 2026 | SEC 8-K |
| Oct 13, 2026 | ACCURAY INC | Mika Nishimura | Class II directorClass II director | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Peter Harwin | directordirector | Appointed | Oct 13, 2026 | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Robert W. Postma | directordirector | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Michael A. Jerman | directordirector | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Alaunos Therapeutics, Inc. | Jaime W. Vieser | directordirector | Departed | n/a | SEC 8-K |
| Oct 13, 2026 | Avery Dennison Corp | Helen J. Sheirbon | President, Solutions GroupPresident | Appointed | Nov 3, 2026 | SEC 8-K |
| Oct 13, 2026 | Bausch & Lomb Corp | Brent Saunders | Chief Executive OfficerCEO | Departed | Oct 12, 2026 | SEC 8-K |
| Oct 13, 2026 | Bausch & Lomb Corp | Thomas J. Appio | interim Chief Executive OfficerCEO | Appointed | Oct 12, 2026 | SEC 8-K |
| Oct 13, 2026 | Bausch & Lomb Corp | Thomas J. Appio | interim Chief Executive OfficerCEO | Appointed | Oct 12, 2026 | SEC 8-K |
| Oct 13, 2026 | Brightline Interactive, Inc./NV | William Keneally | Chief Financial OfficerCFO | Appointed | Jun 1, 2026 | SEC 8-K |
- TEG OVERSEAS, INC.Departed
Victor Balan CEO
Filed Oct 14, 2026Effective Jun 5, 2026SEC 8-K
- TEG OVERSEAS, INC.Departed
Marcelo Ramon Alarcon Martinez Director
Filed Oct 14, 2026Effective Jun 5, 2026SEC 8-K
- TEG OVERSEAS, INC.Departed
Anna Toczko Director
Filed Oct 14, 2026Effective Jun 5, 2026SEC 8-K
- TEG OVERSEAS, INC.Appointed
Elmurod Sopiev CEO
Filed Oct 14, 2026Effective Jun 5, 2026SEC 8-K
- TEG OVERSEAS, INC.Appointed
Temur Zokirov CFO
Filed Oct 14, 2026Effective Jun 5, 2026SEC 8-K
- TEG OVERSEAS, INC.Appointed
Bahtiyor Kadirov Director
Filed Oct 14, 2026Effective Jun 5, 2026SEC 8-K
- TEG OVERSEAS, INC.Appointed
Elina Davidyan Director
Filed Oct 14, 2026Effective Jun 5, 2026SEC 8-K
- Verastem, Inc.Departed
Daniel W. Paterson CEO
Filed Oct 14, 2026Effective Jan 1, 2027SEC 8-K
- Verastem, Inc.Appointed
Michael Bailey CEO
Filed Oct 14, 2026Effective Jan 1, 2027SEC 8-K
- XTI Aerospace, Inc.Appointed
Allan Evans Class I director
Filed Oct 14, 2026Effective Oct 14, 2026SEC 8-K
- ACCURAY INCDeparted
Mika Nishimura Class II director
Filed Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Appointed
Peter Harwin director
Filed Oct 13, 2026Effective Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Departed
Robert W. Postma director
Filed Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Departed
Michael A. Jerman director
Filed Oct 13, 2026SEC 8-K
- Alaunos Therapeutics, Inc.Departed
Jaime W. Vieser director
Filed Oct 13, 2026SEC 8-K
- Avery Dennison CorpAppointed
Helen J. Sheirbon President
Filed Oct 13, 2026Effective Nov 3, 2026SEC 8-K
- Bausch & Lomb CorpDeparted
Brent Saunders CEO
Filed Oct 13, 2026Effective Oct 12, 2026SEC 8-K
- Bausch & Lomb CorpAppointed
Thomas J. Appio CEO
Filed Oct 13, 2026Effective Oct 12, 2026SEC 8-K
- Bausch & Lomb CorpAppointed
Thomas J. Appio CEO
Filed Oct 13, 2026Effective Oct 12, 2026SEC 8-K
- Brightline Interactive, Inc./NVAppointed
William Keneally CFO
Filed Oct 13, 2026Effective Jun 1, 2026SEC 8-K